Gland Pharma Competitors and Similar CompaniesClear all

Gland Pharma's competitors and similar companies include Syner-Med, Photocure, Medexus Pharma and ESSA Pharma.

	Gland Pharma Gland Pharma is a company manufacturing generic injectables.	Syner-Med Syner-Med is a company dedicated to the development and marketing of pharmaceutical products, medical devices as well as licensing.	Photocure Photocure engages in the research, development, production, distribution of pharmaceutical products and related technical medical equipment.	Medexus Pharma Medexus Pharma is a pharmaceutical company developing therapies for autoimmune diseases and cancer.	ESSA Pharma ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer.
Founding Date	Founding Date 1978	Founding Date 1995	Founding Date 1997	Founding Date 2012	Founding Date 2009
Type	Type Public	Type Private	Type Public	Type Subsidiary	Type Public
Tags	Tags Manufacturing & Industrial drug development medical devices oncology pharma	Tags Healthcare drug development medical devices oncology pharma	Tags Healthcare Manufacturing & Industrial drug development medical devices oncology pharma	Tags Healthcare drug development medical devices medtech oncology pharma	Tags Manufacturing & Industrial drug development oncology pharma
Locations	Locations Hyderabad, IN HQ Hyderabad, IN Hyderabad, IN Hyderabad, IN Hyderabad, IN Visakhapatnam, IN Visakhapatnam, IN see more	Locations Purley, GB HQ Teteringen, NL	Locations Ullern, NO HQ Düsseldorf, DE Princeton, US	Locations Chicago, US HQ	Locations Vancouver, CA HQ Houston, US South San Francisco, US
Employees	Employees 4,217	Employees 18	Employees 99	Employees 106	Employees 35
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 127.5 m	Valuation ($) N/A	Valuation ($) 240 m
Financial
Revenue (est.)	Revenue (est.) ₹64.3b (FY, 2026)	Revenue (est.) N/A	Revenue (est.) kr532.6m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods ₹22.4b (FY, 2026)	Cost of goods N/A	Cost of goods kr29.2m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit ₹45b (FY, 2026)	Gross profit N/A	Gross profit kr503.4m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ₹10.3b (FY, 2026)	Net income N/A	Net income (kr1.5m) (FY, 2025)	Net income N/A	Net income ($28.5m) (FY, 2024)
Funding
Total funding raised	Total funding raised $ 200m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 74.1m